British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
Kennedy, Nicholas A Jones, Gareth-Rhys Lamb, Christopher A Appleby, Richard Arnott, Ian Beattie, R Mark Bloom, Stuart Brooks, Alenka J Cooney, Rachel Dart, Robin J
Kennedy, Nicholas A
Jones, Gareth-Rhys
Lamb, Christopher A
Appleby, Richard
Arnott, Ian
Beattie, R Mark
Bloom, Stuart
Brooks, Alenka J
Cooney, Rachel
Dart, Robin J
Abstract
The COVID-19 pandemic is putting unprecedented pressures on healthcare systems globally. Early insights have been made possible by rapid sharing of data from China and Italy. In the UK, we have rapidly mobilised inflammatory bowel disease (IBD) centres in order that preparations can be made to protect our patients and the clinical services they rely on. This is a novel coronavirus; much is unknown as to how it will affect people with IBD. We also lack information about the impact of different immunosuppressive medications. To address this uncertainty, the British Society of Gastroenterology (BSG) COVID-19 IBD Working Group has used the best available data and expert opinion to generate a risk grid that groups patients into highest, moderate and lowest risk categories. This grid allows patients to be instructed to follow the UK government's advice for shielding, stringent and standard advice regarding social distancing, respectively. Further considerations are given to service provision, medical and surgical therapy, endoscopy, imaging and clinical trials.
MIDER Authors
Citations
Altmetric:
Date
2020-04-17
Type
Article
Subject
Gastroenterology
Citation
Kennedy NA, Jones GR, Lamb CA, Appleby R, Arnott I, Beattie RM, Bloom S, Brooks AJ, Cooney R, Dart RJ, Edwards C, Fraser A, Gaya DR, Ghosh S, Greveson K, Hansen R, Hart A, Hawthorne AB, Hayee B, Limdi JK, Murray CD, Parkes GC, Parkes M, Patel K, Pollok RC, Powell N, Probert CS, Raine T, Sebastian S, Selinger C, Smith PJ, Stansfield C, Younge L, Lindsay JO, Irving PM, Lees CW. British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic. Gut. 2020 Jun;69(6):984-990. doi: 10.1136/gutjnl-2020-321244. Epub 2020 Apr 17.
Journal / Source Title
Gut
DOI
10.1136/gutjnl-2020-321244
PMID
32303607
Publisher
British Medical Association
Publisher’s URL
https://gut.bmj.com/